[1] |
Verroust PJ, Wilson CB, Cooper NR, et al. Glomerular complement components in human glomerulonephritis[J]. J Clin Invest, 1974, 53(1): 77-84.
|
[2] |
Fakhouri F, Frémeaux-Bacchi V, Noёl LH, et al. C3 glomerulopathy: a new classification[J]. Nat Rev Nephrol, 2010, 6(8): 494-499.
|
[3] |
Pickering MC, D′Agati VD, Nester CM, et al. C3 glomerulopathy: consensus report[J]. Kidney Int, 2013, 84(6): 1079-1089.
|
[4] |
Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4): c179-c184.
|
[5] |
徐可,肖慧捷,丁洁,等. 急性链球菌感染后肾小球肾炎与C3肾小球病的关系[J]. 中华实用儿科临床杂志,2016, 31(17): 1296-1299.
|
[6] |
Al-Ghaithi B, Chanchlani R, Riedl M, et al. C3 glomerulopathy and post-infectious glomerulonephritis define a disease spectrum[J]. Pediatr Nephrol, 2016, 31(11): 2079-2086.
|
[7] |
Khalighi MA, Wang S, Henriksen KJ, et al. Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy[J]. Clin Kidney J, 2016, 9(3): 397-402.
|
[8] |
Mathern DR, Heeger PS. Molecules great and small: the complement system[J]. Clin J Am Soc Nephrol, 2015, 10(9): 1636-1650.
|
[9] |
陈华,姚勇,王智侠,等. 以新月体肾炎为表现的C3肾小球肾炎一例[J]. 中国小儿急救医学,2015, 22(1): 68-70.
|
[10] |
Rabasco C, Cavero T, Román E, et al. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis[J]. Kidney Int, 2015, 88(5): 1153-1160.
|
[11] |
Oosterveld MJ, Garrelfs MR, Hoppe B, et al. Eculizumab in pediatric dense deposit disease[J]. Clin J Am Soc Nephrol, 2015, 10(10): 1773-1782.
|
[12] |
Gurkan S, Fyfe B, Weiss L, et al. Eculizumab and recurrent C3 glomerulonephritis[J]. Pediatr Nephrol, 2013, 28(10): 975-1981.
|
[13] |
Rousset-Rouviere C, Cailliez M, Garaix F, et al. Rituximab fails where eculizumab restores renal function in C3nef-related DDD[J]. Pediatr Nephrol, 2014, 29(6): 1107-1111.
|
[14] |
Zhang Y, Nester CM, Martin B, et al. Defining the complement biomarker profile of C3 glomerulopathy[J]. Clin J Am Soc Nephrol, 2014, 9(11): 1876-1882.
|
[15] |
Zhang Y, Nester CM, Holanda DG, et al. Soluble CR1 therapy improves complement regulation in C3 glomerulopathy[J]. J Am Soc Nephrol, 2013, 24(11): 1820-1829.
|
[16] |
Dimitrova V, Minkova V, Belovezhdov N. Mesangial C3-glomerulonephritis[J]. Vutr Boles, 1991, 30(2): 47-50.
|
[17] |
Yagi K, Yanagida H, Sugimoto K, et al. Clinicopathologic features, outcome, and therapeutic interventions in four children with isolated C3 mesangial proliferative glomerulonephritis[J]. Pediatr Nephrol, 2005, 20(9): 1273-1278.
|
[18] |
汪瑛,林强,朱赟,等. 儿童C3肾小球肾炎7例[J]. 中华实用儿科临床杂志,2013, 28(5): 349-351.
|